SMI Expanded
1 723,31
|
12,85
|
0,75 %
|
Analysen zu SMI Expanded-Werten
15.10.25 | Nestlé Hold | Deutsche Bank AG | |
15.10.25 | Givaudan Hold | Deutsche Bank AG | |
15.10.25 | Givaudan Buy | Goldman Sachs Group Inc. | |
15.10.25 | Givaudan Neutral | UBS AG | |
15.10.25 | Givaudan Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
14.10.25 | ABB Sector Perform | RBC Capital Markets | |
14.10.25 | Givaudan Neutral | UBS AG | |
14.10.25 | Givaudan Hold | Jefferies & Company Inc. | |
14.10.25 | Givaudan Neutral | JP Morgan Chase & Co. | |
13.10.25 | Swiss Re Underperform | RBC Capital Markets | |
13.10.25 | Roche Buy | UBS AG | |
13.10.25 | Novartis Neutral | UBS AG | |
13.10.25 | ams-OSRAM Buy | Jefferies & Company Inc. | |
13.10.25 | Roche Underweight | JP Morgan Chase & Co. | |
10.10.25 | Novartis Neutral | UBS AG | |
10.10.25 | ABB Sell | Deutsche Bank AG | |
10.10.25 | Richemont Overweight | JP Morgan Chase & Co. | |
10.10.25 | Nestlé Neutral | JP Morgan Chase & Co. | |
09.10.25 | ABB Neutral | Goldman Sachs Group Inc. | |
09.10.25 | ABB Sell | Deutsche Bank AG | |
09.10.25 | Richemont Hold | Deutsche Bank AG | |
09.10.25 | Givaudan Neutral | JP Morgan Chase & Co. | |
08.10.25 | Swiss Re Hold | Jefferies & Company Inc. | |
08.10.25 | Zurich Insurance Hold | Jefferies & Company Inc. | |
08.10.25 | Givaudan Hold | Jefferies & Company Inc. | |
08.10.25 | ABB Sector Perform | RBC Capital Markets | |
08.10.25 | UBS Buy | Deutsche Bank AG | |
08.10.25 | ABB Neutral | JP Morgan Chase & Co. | |
08.10.25 | Givaudan Overweight | JP Morgan Chase & Co. | |
08.10.25 | Givaudan Neutral | UBS AG | |
08.10.25 | Roche Underweight | JP Morgan Chase & Co. | |
07.10.25 | Roche Underweight | JP Morgan Chase & Co. | |
07.10.25 | UBS Outperform | RBC Capital Markets | |
07.10.25 | DocMorris Equal Weight | Barclays Capital | |
07.10.25 | Roche Sell | Goldman Sachs Group Inc. | |
07.10.25 | DocMorris Buy | Jefferies & Company Inc. | |
06.10.25 | UBS Underweight | Morgan Stanley | |
06.10.25 | Richemont Neutral | Goldman Sachs Group Inc. | |
06.10.25 | Novartis Buy | Deutsche Bank AG | |
03.10.25 | UBS Underweight | Barclays Capital |